News & Updates
Filter by Specialty:
Artificial pancreas yields good results in type 2 diabetes patients
A fully closed-loop insulin delivery system, also known as artificial pancreas, helps improve the management of type 2 diabetes in adults, increasing the time spent in target glucose range by 8 hours per day without promoting hypoglycaemic events as compared with standard insulin therapy, as reported in a study.
Artificial pancreas yields good results in type 2 diabetes patients
17 Jan 2023
Higher LDL triglycerides up atherosclerotic CVD risk
Elevated low-density lipoprotein (LDL) triglycerides appear to increase the risk of atherosclerotic cardiovascular disease (ASCVD) and of each ASCVD component, according to a study.
Higher LDL triglycerides up atherosclerotic CVD risk
16 Jan 2023
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
16 Jan 2023
Diet with hyperinsulinaemic potential ups risk of breast cancer
Women with a dietary pattern contributing to hyperinsulinaemia and insulin resistance appear to be at increased risk of breast cancer, particularly estrogen-receptor (ER)-negative and human epidermal growth factor receptor 2 (HER2)-enriched tumours, reveals a study.